TWO LEADING suppliers of analytical tools to laboratories worldwide have announced a new alliance to offer complementary technologies which they hope will help clinical researchers boost lipidomics research.
By integrating their systems, Agilent Technologies and Premier Biosoft say they hope to enable researchers to seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.
Agilent’s contribution to this arrangement is its advanced time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software. These will be integrated with Premier Biosoft’s SimLipid 3.3 identification and quantification software to enable scientists to overcome many of the obstacles inherent in lipid identification and analysis. The companies say this will give them a distinct advantage in mapping the lipid pathways associated with metabolic disease.
“Identifying and sequencing the thousands of lipid species involved in human metabolism is just as challenging as mapping and sequencing the human genome,” said Dr Daniel Kassel, Agilent’s senior director of LC/MS global marketing. “This combined network of technologies gives researchers confidence .”